All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML
Kinase inhibitors inhibit downstream signaling pathways and thereby interfere with survival, activation, proliferation, and differentiation of normal and malignant cells. Kinase inhibitors are increasingly used to treat hematological malignancies, including acute leukemias.